Results 51 to 60 of about 54,698 (337)
Monte Carlo-based estimation of patient absorbed dose in 99mTc-DMSA, -MAG3, and -DTPA SPECT imaging using the University of Florida (UF) phantoms [PDF]
arXiv, 2021 SPECT imaging is one of the common modalities used to examine kidney disease. The radiopharmaceuticals such as 99mTc-MAG3, 99mTc-DTPA, and 99mTc-DMSA are commonly employed for pediatric patients. It is generally accepted that children organs are more sensitive to radiation than adults, due to their growth rate.
arxiv
Carbon dots: An innovative luminescent nanomaterial
Aggregate, 2022 In recent years, carbon dots (CDs), including carbon nanodots, carbonized polymer dots, carbon quantum dots, and graphene quantum dots have attracted a mounting interest as readily accessible, nontoxic, and relatively inexpensive carbon‐based ...
Yuxin Shi +12 more
doaj +1 more source
Potential Applications of Artificial Intelligence and Machine Learning in Radiochemistry and Radiochemical Engineering [PDF]
arXiv, 2021 Artificial intelligence and machine learning are poised to disrupt PET imaging from bench to clinic. In this perspective we offer insights into how the technology could be applied to improve the design and synthesis of new radiopharmaceuticals for PET imaging, including identification of an optimal labeling approach as well as strategies for ...
arxiv
Role of AI in Theranostics: Towards Routine Personalized Radiopharmaceutical Therapies [PDF]
arXiv, 2021 We highlight emerging uses of artificial intelligence (AI) in the field of theranostics, focusing on its significant potential to enable routine and reliable personalization of radiopharmaceutical therapies (RPTs). Personalized RPTs require patient-individual dosimetry calculations accompanying therapy.
arxiv
Radiopharmaceuticals: navigating the frontier of precision medicine and therapeutic innovation
European Journal of Medical ResearchThis review article explores the dynamic field of radiopharmaceuticals, where innovative developments arise from combining radioisotopes and pharmaceuticals, opening up exciting therapeutic possibilities.
Shivang Dhoundiyal +7 more
semanticscholar +1 more source
Nuclear medicine as a tool for diagnosis and targeted cancer therapy
Бюллетень сибирской медицины, 2018 The main trends and prospects of development of nuclear medicine, problems and possible ways of their solution are considered in the article. The main scientific directions in the development of radiopharmaceuticals for the diagnosis and radionuclide ...
V. I. Chernov +5 more
doaj +1 more source
EJNMMI Physics, 2023 Background Highly sensitive digital total-body PET/CT scanners (uEXPLORER) have great potential for clinical applications and fundamental research. Given their increasing sensitivity, low-dose scanning or snapshot imaging is now possible in clinics ...
Yanchao Huang +10 more
doaj +1 more source
Close contact restriction periods for patients who received iodine-131 therapy for differentiated thyroid cancer [PDF]
, 2022 Objective. Patients treated with radionuclide therapy may require restrictions on certain activities for a period of time following treatment to optimise protection of the public and ensure the legal dose limit is not exceeded. Software may be used to calculate necessary restriction periods for an individual based on longitudinal dose rate measurements
arxiv +1 more source
Carrier systems of radiopharmaceuticals and the application in cancer therapy
Cell Death DiscoveryRadiopharmaceuticals play a vital role in cancer therapy. The carrier of radiopharmaceuticals can precisely locate and guide radionuclides to the target, where radionuclides kill surrounding tumor cells.
Taotao Zhang +12 more
semanticscholar +1 more source
Bioinorganic Chemistry and Applications, 2009 A neutral compound Re(CO)3(L) (L: 2-((2-(2,6-diethylphenylamino)-2-oxoethyl)(2-ethoxy-2-oxoethyl)amino)acetic acid, an IDA analogue) has been synthesized and evaluated for in vitro imaging probes of β-amyloid (Aβ) aggregates.
Yang Yang +3 more
doaj +1 more source